Fiasp (Insulin Aspart) Will Be Another Mealtime Insulin Alternative
December 2017
Reps will promote Fiasp (FEE-asp, insulin aspart) as an "ultrafast-acting" mealtime insulin for adults.
Think of Fiasp as similar to NovoLog. They're both insulin aspart from the same company...except Fiasp has an additive to speed absorption.
Fiasp starts working about 5 minutes faster than NovoLog.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote